drugset
drugset / Trial / NCT00006227

Paclitaxel in Treating Patients With Ovarian Stromal Cancer

NCT00006227 ↗

Phase 2 Completed 31 enrolled Gynecologic Oncology Group National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies the effectiveness of paclitaxel in treating patients who have ovarian stromal cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start
2000-11-20
Primary completion
2016-07-16
Completion
2016-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule — Intravenous

Indications

ovarian Sertoli-Leydig cell tumor ovarian granulosa cell tumor ovarian gynandroblastoma